Publikationen Archiv - Seite 6 von 8

Feißel, A., Arnold, K., Häckl, D., Kliemt, R., Küster, D., Milarczyk, J., Neumann, A., Pfennig, A., Schmitt, J. M., Swart, E., Weiß, J. & March, S. (2016). Herausforderungen beim Datenhandling am Beispiel einer routinedatenbasierten und kassenübergreifenden Studie zur wissenschaftlichen Evaluation von Modellvorhaben nach §64b SGB V (EVA64). Das Gesundheitswesen, 78(08/09), S. A186. DOI:https://doi.org/10.1055/s-0036-1586695 (abgerufen am 25.10.2023).

Therapy areas: Psychiatry

Indications: Mental disorders

Kåre I Birkeland, Johan Bodegard, Jan W Eriksson, Anna Norhammar, Hermann Haller, Gerard C M Linssen, Amitava Banerjee, Marcus Thuresson, Suguru Okami, Elena Garal-Pantaler, Jetty Overbeek, Jil Billy Mamza, Ruiqi Zhang, Toshitaka Yajima, Issei Komuro, Takashi Kadowaki. Heart failure and chronic kidney disease manifestation and mortality risk associations in type 2 diabetes: A large multinational cohort study. Diabetes Obes Metab. 2020;22:1607–1618. DOI: 10.1111/dom.14074

Therapy areas: Cardiovascular, Renal and Metabolism

Indications: Diabetes Type 2

Parsekar K, Kossack N, Hernández I, Vogelmeier CF, Kolb N, Baak B, Swart-Polinder KMA, Simons S, Bengtsson C, Vojinovic-Dees D, Sin D, Hawkins N, McMullen S, Pham T, Corregidor García C, Martinez N, Sánchez-Covisa Hernández J, Abram M, Halbach M, van Burk L, Randhawa A, Nordon C. Healthcare Resource Utilization and Costs in Patients Experiencing Severe Cardiac Events Following a COPD Exacerbation: Results from the EXACOS-CV Studies in Spain, Germany , the Netherlands and Canada. Value in Health, Volume 26, Issue 11, S2 (December 2023). No DOI/URL available

Therapy areas: Respiratory

Indications: COPD

Parsekar, K., Kossack, N., Hernández, I., Vogelmeier, C. F., Kolb, N., Baak, B. N., Swart-Polinder, K. M. A., Simons, S. O., Bengtsson, C., Vojinovic-Dees, D., Sin, D. D., Hawkins, N. M., McMullen, S., Pham, T., Corregidor García, C., Martinez, N., Sánchez-Covisa Hernández, J., Abram, M., Halbach, M., van Burk, L., Randhawa, A. & Nordon, C. (2023). Healthcare Resource Utilization and Costs in Patients Experiencing Severe Cardiac Events Following a COPD Exacerbation: Results from EXACOS-CV Studies in Spain, Germany, the Netherlands and Canada. [Vortrag]. ISPOR Europe 2023. ISPOR, 12.11.2023, Kopenhagen. Online: https://www.ispor.org/heor-resources/presentations-database/presentation/euro2023-3784/129353 (abgerufen am 03.01.2024).

Therapy areas: Respiratory

Indications: COPD

CF. Vogelmeier, N. Kossack, N. Kolb, C. Nordon, K. Rhodes, M. Abram, M. Halbach, M. Gediga. Healthcare resource utilisation in COPD patients experiencing severe cardiac events: Results from EXACOS-CV studies in Germany. Kongress der Deutschen Gesellschaft für Pneumologie (DGP), Mannheim, March 20, 2024 No DOI/URL available

Therapy areas: Respiratory

Indications: COPD

ER Hammond, H Friedel, E Garal-Pantaler, M Pignot, E Velthuis, X Wang, H Nab, B Desta, A Schwarting. Health Care Resource Use (HRU) and Medical Costs Analyses as a Function of Systemic Lupus Erythematosus (SLE) Disease Severity: Analysis of Claims Data of a German Sickness Fund. LUPUS 2018;5(Suppl 1):A1–A129, DOI: 10.1136/lupus-2018-abstract.204

Therapy areas: Immunology

Indications: Systemic Lupus Erythematosus

E.R. Hammond, H. Friedel, E. Garal-Pantaler, M. Pignot, E. Velthuis, X.Wang, H.Nab, B.Desta, A. Schwarting. Health Care Resource Utilisation (HCRU) and Cost Analyses of Systemic Lupus Erythematosus (SLE) as a Function of Disease Severity: Analysis of Real-World Claims Data from a German Sickness Fund. Ann. Rheum. Dis. 2018, DOI: 10.1136/annrheumdis-2018-eular.5150

Therapy areas: Immunology

Indications: Systemic Lupus Erythematosus

Bo Ding, Marc Pignot, Elena Garal-Pantaler, Beate Villinger, Barnabas Desta, Katharina Schmidt, Sarowar Golam, Heide Stirnadel-Farrant, Andreas Schwarting Clinical Characteristics, Health Care Resource Utilization, and Costs Associated With Flares in Patients With Systemic Lupus Erythematosus in Germany EULAR 2022 No DOI/URL available

Therapy areas: Immunology

Indications: Systemic Lupus Erythematosus

Edward R Hammond, Heiko Friedel, Elena Garal-Pantaler, Marc Pignot, Erica Velthuis, Xia Wang, Henk Nab, Barnabas Desta, Andreas Schwarting. Health Care Costs of Patients With Systemic Lupus Erythematosus (SLE) Versus Control Patients as a Function of Disease Severity: Analysis of the Betriebskrankenkassen German Sickness Fund. ACR/ARHP Annual Meeting 2017, San Diego No DOI/URL available

Therapy areas: Immunology

Indications: Systemic Lupus Erythematosus

Vogelmeier CF, Beeh KM, Schultze M, Kossack N, Richter LM, Claussen J, Compton C, Noorduyn SG, Ismaila AS, Requena G. Evaluation of Adherence and Persistence to Triple Therapy in Patients with COPD: A German Claims Data Study. Int J Chron Obstruct Pulmon Dis. 2024;19:1835-1848. https://doi.org/10.2147/COPD.S460903

Therapy areas: Respiratory

Indications: COPD

Ständer, S., Ketz, M., Kossack, N., Akumo, D., Pignot, M., Gabriel, S. & Chavda, R. (2020). Epidemiology of Prurigo Nodularis compared with Psoriasis in Germany: A Claims Database Analysis. Acta Derm Venereol. (Acta Dermato-Venereologica), 100(18), S. adv00309. DOI:https://doi.org/10.2340/00015555-3655 (abgerufen am 02.11.2023).

Therapy areas: Dermatology

Indications: Prurigo Nodularis

Neumann, A., Hense, H., Baum, F., Kliemt, R., Seifert, M., Harst, L., Kubat, D., Maicher, B., Schrey, C., Schmitt, J. M., Pfennig, A., Weinhold, I., Swart, E. & Soltmann, B. (2021). Evaluation of a flexible and integrative psychiatric care model in a department of child and adolescent psychiatry in Tübingen, Germany: study protocol (EVA_TIBAS). BMC health services research, 21(1), S. 1262. DOI:https://doi.org/10.1186/s12913-021-07226-1.

Therapy areas: Psychiatry

Indications: Mental disorders

M. Hilz, P. DasMahapatra, Q. Fan, F. Marczykowski, B.Werner, M.Pignot, J. Bender, R. Punekar. A Hamed, M. Edigkaufer. Evaluation of Treatment Patterns of Fabry Disease Utilizing Medical Claims Analyses of a German Sickness Fund Database. Value in Health 2020 VOLUME 23, SUPPLEMENT 1, S347. DOI: doi.org/10.1016/j.jval.2020.04.1321

Therapy areas: Rare Disease

Indications: Fabry Disease

Kossack, N., Schindler, C., Weinhold, I., Hickstein, L., Lehne, M., Walker, J., Neubauer, A. S. & Häckl, D. (2018). German claims data analysis to assess impact of different intraocular lenses on posterior capsule opacification and related healthcare costs. Journal of Public Health, 26(1), S. 81–90. DOI:https://doi.org/10.1007/s10389-017-0851-y (abgerufen am 30.10.2023).

Therapy areas: Ophthalmology

Indications: Cataract

Kliemt, R., Claus, F., Weinhold, I., Baum, F., March, S., Neumann, A., Schoffer, O., Seifert, M., Swart, E., Schmitt, J. M. & Häckl, D. (2018). Gesundheitsökonomische Evaluation von Modellprojekten zur Versorgung psychisch kranker Menschen nach §64b SGB V – erste Ergebnisse von 12 Kliniken. In: Deutsches Netzwerk Versorgungsforschung e. V. (Hrsg.). 17. Deutscher Kongress für Versorgungsforschung, 10.–12.10.2018, Berlin. DOI:https://doi.org/10.3205/18DKVF065.

Therapy areas: Psychiatry

Indications: Mental disorders

Vogelmeier, C. F., Rhodes, K., Garbe, E., Abram, M., Halbach, M., Müllerová, H., Kossack, N., Timpel, P., Kolb, N. & Nordon, C. (2024). Elucidating the risk of cardiopulmonary consequences of an exacerbation of COPD: results of the EXACOS-CV study in Germany. BMJ open respiratory research, 11(1). DOI: https://doi.org/10.1136/bmjresp-2023-002153.

Therapy areas: Respiratory

Indications: COPD

Weinhold, I., Schindler, C., Kossack, N., Berndt, B. & Häckl, D. (2019). Economic impact of disease prevention in a morbidity-based financing system: does prevention pay off for a statutory health insurance fund in Germany? The European journal of health economics : HEPAC : health economics in prevention and care, 20(8), S. 1181–1193. DOI:https://doi.org/10.1007/s10198-019-01086-7 (abgerufen am 18.09.2023).

Therapy areas: General Health

Indications: General

Schultze M, Garal-Pantaler E, Pignot M, Carnarius H, Gairy K, Levy R. Economic Burden of Organ Damage in Systemic Lupus Erythematosus: Results From a German Claims Analysis. DGRh Kongress 2021. doi: 10.3205/21dgrh064

Therapy areas: Immunology

Indications: Systemic Lupus Erythematosus

Balfanz, P., Hartmann, B., Müller-Wieland, D., Kleines, M., Häckl, D., Kossack, N., Kersten, A., Cornelissen, C., Müller, T., Daher, A., Stöhr, R., Bickenbach, J., Marx, G., Marx, N. & Dreher, M. (2021). Early risk markers for severe clinical course and fatal outcome in German patients with COVID-19. PLoS ONE, 16(1), S. e0246182. DOI:https://doi.org/10.1371/journal.pone.0246182.

Therapy areas: Infectious Diseases

Indications: COVID-19

Sonja Ständer, Miriam Ketz, Nils Kossack, Marc Pignot, Rajeev Chavda, Sylvie Gabriel. Disease Burden, Healthcare Resource Utilization & Treatment Pattern among Patients with Prurigo Nodularis compared to a Benchmark in Germany: A Real-World-Evidence Claims Data Study. 31st EADV Congress, Milan 2022. No DOI/URL available

Therapy areas: Dermatology

Indications: Prurigo Nodularis

1 2 3 4 5 6 7 8

Publikationen

154